KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ginkgo Bioworks Holdings (DNA) Accumulated Depreciation (2020 - 2023)

Ginkgo Bioworks Holdings (DNA) has disclosed Accumulated Depreciation for 3 consecutive years, with $118.5 million as the latest value for Q2 2023.

  • For the quarter ending Q2 2023, Accumulated Depreciation rose 51.47% year-over-year to $118.5 million, compared with a TTM value of $118.5 million through Jun 2023, up 51.47%, and an annual FY2022 reading of $92.8 million, up 51.93% over the prior year.
  • Accumulated Depreciation was $118.5 million for Q2 2023 at Ginkgo Bioworks Holdings, up from $92.8 million in the prior quarter.
  • Across five years, Accumulated Depreciation topped out at $118.5 million in Q2 2023 and bottomed at $61.1 million in Q4 2021.
  • Average Accumulated Depreciation over 3 years is $87.6 million, with a median of $85.5 million recorded in 2022.
  • The sharpest move saw Accumulated Depreciation skyrocketed 51.93% in 2022, then skyrocketed 51.47% in 2023.
  • Year by year, Accumulated Depreciation stood at $61.1 million in 2021, then surged by 51.93% to $92.8 million in 2022, then increased by 27.72% to $118.5 million in 2023.
  • Business Quant data shows Accumulated Depreciation for DNA at $118.5 million in Q2 2023, $92.8 million in Q4 2022, and $78.2 million in Q2 2022.